162 related articles for article (PubMed ID: 37507701)
1. GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer.
Wu L; Zhang Y; Zheng C; Zhao F; Lin Y
BMC Womens Health; 2023 Jul; 23(1):396. PubMed ID: 37507701
[TBL] [Abstract][Full Text] [Related]
2. Identification of key pathways and hub genes in basal-like breast cancer using bioinformatics analysis.
Yang K; Gao J; Luo M
Onco Targets Ther; 2019; 12():1319-1331. PubMed ID: 30863098
[TBL] [Abstract][Full Text] [Related]
3. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
[TBL] [Abstract][Full Text] [Related]
4. Identification and evaluation of network modules for the prognosis of basal-like breast cancer.
Hallett RM; Cockburn JG; Li B; Dvorkin-Gheva A; Hassell JA; Bane A
Oncotarget; 2015 Jul; 6(19):17713-24. PubMed ID: 25991675
[TBL] [Abstract][Full Text] [Related]
5. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
[TBL] [Abstract][Full Text] [Related]
6. Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer.
Li CI; Zhang Y; Cieślik M; Wu YM; Xiao L; Cobain E; Tang MC; Cao X; Porter P; Guenthoer J; Robinson DR; Chinnaiyan AM
Clin Cancer Res; 2021 Jun; 27(11):3079-3093. PubMed ID: 33753452
[TBL] [Abstract][Full Text] [Related]
7. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
She QB; Gruvberger-Saal SK; Maurer M; Chen Y; Jumppanen M; Su T; Dendy M; Lau YK; Memeo L; Horlings HM; van de Vijver MJ; Isola J; Hibshoosh H; Rosen N; Parsons R; Saal LH
BMC Cancer; 2016 Aug; 16():587. PubMed ID: 27484095
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of key gene modules and pathways of human breast cancer cell lines.
Wu Y; Liu F; Luo S; Yin X; He D; Liu J; Yue Z; Song J
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31285391
[TBL] [Abstract][Full Text] [Related]
9. Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis.
Liu D; Vadgama J; Wu Y
Int J Biol Sci; 2021; 17(3):670-682. PubMed ID: 33767579
[TBL] [Abstract][Full Text] [Related]
10. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
11. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
[No Abstract] [Full Text] [Related]
12. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
13. Using weighted gene co-expression network analysis (WGCNA) to identify the hub genes related to hypoxic adaptation in yak (Bos grunniens).
Bao Q; Zhang X; Bao P; Liang C; Guo X; Chu M; Yan P
Genes Genomics; 2021 Oct; 43(10):1231-1246. PubMed ID: 34338989
[TBL] [Abstract][Full Text] [Related]
14. The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.
Shepherd JH; Uray IP; Mazumdar A; Tsimelzon A; Savage M; Hilsenbeck SG; Brown PH
Oncotarget; 2016 Mar; 7(11):13106-21. PubMed ID: 26894864
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer.
Zhang Y; Liu J; Raj-Kumar PK; Sturtz LA; Praveen-Kumar A; Yang HH; Lee MP; Fantacone-Campbell JL; Hooke JA; Kovatich AJ; Shriver CD; Hu H
Breast Cancer Res Treat; 2020 Dec; 184(3):689-698. PubMed ID: 32880016
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterisation of a nuclear localisation signal in the SMN associated protein, Gemin4.
Lorson MA; Dickson AM; Shaw DJ; Todd AG; Young EC; Morse R; Wolstencroft C; Lorson CL; Young PJ
Biochem Biophys Res Commun; 2008 Oct; 375(1):33-7. PubMed ID: 18675250
[TBL] [Abstract][Full Text] [Related]
17. Identification of Hub Genes as Biomarkers Correlated with the Proliferation and Prognosis in Lung Cancer: A Weighted Gene Co-Expression Network Analysis.
Xu X; Xu L; Huang H; Li J; Dong S; Jin L; Ma Z; Li L
Biomed Res Int; 2020; 2020():3416807. PubMed ID: 32596300
[TBL] [Abstract][Full Text] [Related]
18. Coexpression Module Construction by Weighted Gene Coexpression Network Analysis and Identify Potential Prognostic Markers of Breast Cancer.
Wang Y; Cui K; Zhu M; Gu Y
Cancer Biother Radiopharm; 2022 Oct; 37(8):612-623. PubMed ID: 33052716
[No Abstract] [Full Text] [Related]
19. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
20. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]